Intravitreal bevacizumab (Avastin®) for diabetic retinopathy at 24-months: The 2008 Juan Verdaguer-planas lecture
- Pan-American Collaborative Retina Study Group (PACORES)
Research output: Contribution to journal › Article › peer-review
25
Link opens in a new tab
Scopus
citations